Notice2023-27575
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 15, 2023
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 240 (Friday, December 15, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 240 (Friday, December 15, 2023)]
[Notices]
[Page 86938]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-27575]
[[Page 86938]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium
Notice is hereby given that, on October 13, 2023, pursuant to
section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical CBRN Defense
Consortium (``MCDC'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, Compleo Technologies LLC, Newtown, CT; Core4ce LLC,
Reston, VA; KRI at Northeastern University LLC, Burlington, MA; and
North American Rescue LLC, Greer, SC, have been added as parties to
this venture.
Also, Alltropic Tech, Halethorpe, MD; California Institute for
Biomedical Research, La Jolla, CA; GenArraytion Inc., Rockville, MD;
Integrated Biotherapeutics, Inc., Rockville, MD; International Business
Machines Corp., Yorktown Heights, NY; Luna Labs USA LLC,
Charlottesville, VA; Mesa Tech International, San Diego, CA; Qorvo
Biotechnologies LLC, Bend, OR; Sentinel Analytics Software, Inc.,
Davis, CA; SGSD Partners LLC, Washington, DC; Synthetic Genomics
Vaccines, Inc., La Jolla, CA; Unify R&D, Elkridge, MD; and Vector RX
LLC, Elkridge, MD, have withdrawn as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
On November 13, 2015, MCDC filed its original notification pursuant
to section 6(a) of the Act. The Department of Justice published a
notice in the Federal Register pursuant to section 6(b) of the Act on
January 6, 2016 (81 FR 513).
The last notification was filed with the Department on July 17,
2023. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on October 5, 2023 (88 FR 69231).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2023-27575 Filed 12-14-23; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on December 15, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.